The underlying mechanism was suggested to be that the TNF inhibitor (infliximab) depletes specific immune cells (CD45RA+ effector memory CD8+ T cells), which are critical for the clearance of tuberculosis-infected macrophages [103]. The gene discussed is TNF; the disease is tuberculosis.